These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11757555)

  • 1. A message to the new FDA Commissioner.
    Hatch OG
    Food Drug Law J; 1999; 54(1):5-11. PubMed ID: 11757555
    [No Abstract]   [Full Text] [Related]  

  • 2. New FDA Commissioner sees challenges, opportunities.
    Lewis C
    FDA Consum; 2003; 37(1):9. PubMed ID: 12625298
    [No Abstract]   [Full Text] [Related]  

  • 3. Remarks of the Commissioner of Food and Drugs.
    Henney JE
    Food Drug Law J; 1999; 54(1):1-3. PubMed ID: 11794304
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescription for change: an interview with FDA Commissioner Dr. David Kessler.
    Kessler D
    Physician Assist; 1992 Jul; 16(7):61-2, 65, 68-70. PubMed ID: 10120389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Many issues in store for new FDA commissioner.
    Wadman M
    Nat Rev Drug Discov; 2005 Nov; 4(11):871-2. PubMed ID: 16299912
    [No Abstract]   [Full Text] [Related]  

  • 6. Remarks of the Commissioner of Food and Drugs.
    McClellan MB
    Food Drug Law J; 2003; 58(2):191-204. PubMed ID: 12866552
    [No Abstract]   [Full Text] [Related]  

  • 7. A turbulent year at the agency.
    Ratner M
    Nat Biotechnol; 2006 Feb; 24(2):145-51. PubMed ID: 16465153
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA: a science-based agency.
    Casciano DA
    FDA Consum; 2002; 36(5):40. PubMed ID: 12412554
    [No Abstract]   [Full Text] [Related]  

  • 9. How the FDA looks ahead while celebrating its 75th anniversary.
    Hayes AH
    Pharm Times; 1981 Nov; 47(11):19-21. PubMed ID: 10253562
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA appointee faces angry, demoralized staff.
    Fox JL
    Nat Biotechnol; 2002 Nov; 20(11):1065. PubMed ID: 12410237
    [No Abstract]   [Full Text] [Related]  

  • 11. New office and new leader aim to streamline FDA cancer drug review process.
    Twombly R
    J Natl Cancer Inst; 2005 May; 97(10):708-9. PubMed ID: 15900036
    [No Abstract]   [Full Text] [Related]  

  • 12. Remarks by the Commissioner. FDA.
    Kessler DA
    J Parenter Sci Technol; 1991; 45(3):118-21. PubMed ID: 1886036
    [No Abstract]   [Full Text] [Related]  

  • 13. Of specialty interest: the Food and Drug Administration: a partner in safe practice.
    Baker K
    ORL Head Neck Nurs; 2003; 21(2):25-7. PubMed ID: 12747041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganging up on the FDA.
    Stone PH
    Natl J (Wash); 1995 Feb; 27(7):410-4. PubMed ID: 10140321
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA leadership picks may stress safety over swift approval.
    Dorans K
    Nat Med; 2009 May; 15(5):466. PubMed ID: 19424185
    [No Abstract]   [Full Text] [Related]  

  • 16. A familiar face at the FDA.
    Nat Med; 2005 Nov; 11(11):1125. PubMed ID: 16270047
    [No Abstract]   [Full Text] [Related]  

  • 17. The latest word from the FDA: an exclusive interview with the commissioner. Interview by John A. Owen Jr.
    Hayes AH
    Hosp Formul; 1982 Aug; 17(8):1063-8, 1075. PubMed ID: 10256696
    [No Abstract]   [Full Text] [Related]  

  • 18. Mission: promoting, protecting the public health. FDA Commissioner Mark B. McClellan. Interview by Ray Formanek Jr.
    McClellan MB
    FDA Consum; 2003; 37(2):12-7. PubMed ID: 12715764
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA research: the foundation for sound regulatory decisions.
    FDA Consum; 2006; 40(1):66-7. PubMed ID: 16528830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demystifying the FDA: Commissioner Young punches some holes in the "black box'. Interview by Don L. Gibbons.
    Young FE
    Med World News; 1985 May; 26(9):78-9, 83-4, 89-90 passim. PubMed ID: 10271160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.